Novel regulations of DNA damage repair
Novel regulations of DNA damage repair
批准号:
10087898
负责人:
Junjie Chen
金额:
$43.64万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-16 至 2024-02-28
关键词:
Affinity ChromatographyBRCA mutationsBRCA1 geneBinding ProteinsCancer EtiologyCancer PatientCell DeathCell NucleusCellsChromatinClinicalCoupledDNADNA DamageDNA Double Strand BreakDNA RepairDNA Repair GeneDNA Repair PathwayDNA damage checkpointDNA lesionDataDefectDouble Strand Break RepairGenesGenomeGenomic InstabilityGoalsHumanImmunoglobulin Class SwitchingImmunoglobulin Switch RecombinationKnockout MiceLaboratoriesLeadMaintenanceMalignant NeoplasmsMalignant neoplasm of ovaryMass Spectrum AnalysisMediatingMolecularMutagenesisMutationNonhomologous DNA End JoiningOutcomePathway interactionsPlayPoly(ADP-ribose) PolymerasesProcessProteinsRadiationRegulationResistanceRoleSignal PathwaySiteSourceSun ExposureTumor Suppressor Proteinsbasebrca genecancer therapychemotherapeutic agentdriving forcegenome integrityhomologous recombinationin vivoinhibitor/antagonistmalignant breast neoplasmmutantneoplastic cellnovelp53-binding protein 1patient responserecombinational repairrecruitrepairedresistance mechanismresponsesenescencetargeted cancer therapytherapy resistanttreatment responsetumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Defects in DNA damage response and DNA repair are the driving forces of genomic instability and
tumorigenesis. Gaining a better understanding of the pathways involved in DNA repair not only increases our
understanding of cancer etiology, but also provides new targets for cancer therapies. A key protein involved in
DNA repair and tumorigenesis is p53-binding protein 1, i.e. 53BP1.
My laboratory has been working on 53BP1 for many years. Our group was one of the first to demonstrate
the role of 53BP1 in DNA damage response. We established the first 53bp1 knockout (KO) mice; we also
revealed that 53BP1 is required for DNA repair and acts as a tumor suppressor in vivo. In addition, we
elucidated the regulation of 53BP1 after DNA damage. We and others demonstrated that the H2AX-dependent
DNA damage signaling pathway controls the recruitment and accumulation of 53BP1 at sites of DNA breaks.
However, 53BP1 can also localize to DNA damage sites in an H2AX-independent manner, although the
underlying mechanisms remain to be determined. Moreover, we showed that 53BP1 is critical for a particular
repair process called class-switch recombination, indicating that 53BP1 is involved in a special DNA repair
pathway that is distinctly different from the canonical nonhomologous end-joining pathway. Our recent studies
and those of others suggest that 53BP1 suppresses homologous recombination repair in BRCA1-deficient
cells, which is critically important for response to poly (ADP-ribose) polymerase inhibitor-based cancer
therapies. Together, these data highlight the importance of 53BP1 in counteracting homologous recombination
repair in response to DNA damage. In this proposal, we plan to focus on 53BP1 and elucidate at the molecular
level how 53BP1 is regulated after DNA damage and contributes to DNA repair and genome maintenance.
To further understand the regulation of 53BP1 localization and function at DNA damage sites, we recently
performed tandem affinity purification coupled with mass spectrometry analysis to identify proteins that would
specifically associate with a region of 53BP1, which is necessary and sufficient for its localization to DNA
damage sites. Surprisingly, we uncovered several novel 53BP1-binding proteins, including NUDT16,
NUDT16L1, and DEK. In this proposal, we will 1) further determine the roles of NUDT16L1 and NUDT16 in
53BP1 regulation and in the DNA damage response, and 2) elucidate the functional significance of DEK and
other newly discovered 53BP1-associated proteins in damage-induced 53BP1 localization, DNA repair, and
the maintenance of genomic integrity. These studies will help us understand the key components that act
upstream of 53BP1 and function together with 53BP1 in DNA repair and genome maintenance.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.15252/embj.2021107776
发表时间:
2021-09-01
期刊:
The EMBO journal
影响因子:
--
作者:
[Chen Z, Wang C, Feng X, Nie L, Tang M, Zhang H, Xiong Y, Swisher SK, Srivastava M, Chen J]
通讯作者:
Chen J
DOI:
10.1016/j.jbc.2022.101979
发表时间:
2022-06
期刊:
JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子:
4.8
作者:
[Tang, Mengfan, Chen, Zhen, Wang, Chao, Feng, Xu, Lee, Namsoo, Huang, Min, Zhang, Huimin, Li, Siting, Xiong, Yun, Chen, Junjie]
通讯作者:
Chen, Junjie
DOI:
10.20892/j.issn.2095-3941.2020.0370
发表时间:
2020-11-15
期刊:
Cancer biology & medicine
影响因子:
5.5
作者:
[Szymonowicz KA, Chen J]
通讯作者:
Chen J
DOI:
10.1126/sciadv.abn1606
发表时间:
2022-05-27
期刊:
Science advances
影响因子:
13.6
作者:
[]
通讯作者:
DOI:
10.1073/pnas.2121779119
发表时间:
2022-06-21
期刊:
Proceedings of the National Academy of Sciences of the United States of America
影响因子:
11.1
作者:
[]
通讯作者:
共 11 条
Deciphering pathways involved in topoisomerase II turnover
-
批准号:10552113
-
项目类别:
-
资助金额:$50.3万
-
财政年份:2023
-
负责人:Junjie Chen
-
依托单位:
Elucidating mechanisms underlying replication checkpoint control
-
批准号:10620981
-
项目类别:
-
资助金额:$49.94万
-
财政年份:2023
-
负责人:Junjie Chen
-
依托单位:
Exploring DNA damage response pathways as targets for cancer therapy
-
批准号:10515484
-
项目类别:
-
资助金额:$58.34万
-
财政年份:2022
-
负责人:Junjie Chen
-
依托单位:
Novel regulations of DNA damage repair
-
批准号:9883637
-
项目类别:
-
资助金额:$43.64万
-
财政年份:2017
-
负责人:Junjie Chen
-
依托单位:
Novel regulations of DNA damage repair
-
批准号:9326453
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2017
-
负责人:Junjie Chen
-
依托单位:
Define redundant functions of H2AX and NBS1 in DNA repair
-
批准号:10311996
-
项目类别:
-
资助金额:$35.87万
-
财政年份:2017
-
负责人:Junjie Chen
-
依托单位:
Project 4: Coordinating Nucleolytic Pathways During Crosslink Repair
-
批准号:9148677
-
项目类别:
-
资助金额:$35.43万
-
财政年份:2017
-
负责人:Junjie Chen
-
依托单位:
Define redundant functions of H2AX and NBS1 in DNA repair
-
批准号:9206732
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2017
-
负责人:Junjie Chen
-
依托单位:
Define redundant functions of H2AX and NBS1 in DNA repair
-
批准号:10053713
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2017
-
负责人:Junjie Chen
-
依托单位:
53BP1-dependent pathway in DNA repair
-
批准号:9763542
-
项目类别:
-
资助金额:$35.5万
-
财政年份:2017
-
负责人:Junjie Chen
-
依托单位:
53BP1-dependent pathway in DNA repair
-
批准号:10404655
-
项目类别:
-
资助金额:$35.87万
-
财政年份:2017
-
负责人:Junjie Chen
-
依托单位:
Fanconi anemia pathway in DNA damage repair
-
批准号:8234219
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2012
-
负责人:Junjie Chen
-
依托单位:
Fanconi anemia pathway in DNA damage repair
-
批准号:8467691
-
项目类别:
-
资助金额:$30.82万
-
财政年份:2012
-
负责人:Junjie Chen
-
依托单位:
Fanconi anemia pathway in DNA damage repair
-
批准号:8628642
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2012
-
负责人:Junjie Chen
-
依托单位:
Fanconi anemia pathway in DNA damage repair
-
批准号:8826053
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2012
-
负责人:Junjie Chen
-
依托单位:
MRI BIOMARKERS OF ANGIOGENESIS AND CELL INJURY IN RETINOPATHY OF PREMATURITY
-
批准号:7577530
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2008
-
负责人:Junjie Chen
-
依托单位:
MRI BIOMARKERS OF ANGIOGENESIS AND CELL INJURY IN RETINOPATHY OF PREMATURITY
-
批准号:7450075
-
项目类别:
-
资助金额:$21.76万
-
财政年份:2008
-
负责人:Junjie Chen
-
依托单位:
The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast Cancer
-
批准号:7737070
-
项目类别:
-
资助金额:$20.67万
-
财政年份:2008
-
负责人:Junjie Chen
-
依托单位:
Study the Role of Chfr in Tumorigenesis
-
批准号:7806610
-
项目类别:
-
资助金额:$26.54万
-
财政年份:2006
-
负责人:Junjie Chen
-
依托单位:
Study the Role of Chfr in Tumorigenesis
-
批准号:8232694
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2006
-
负责人:Junjie Chen
-
依托单位:
海外基金